Cardiac output as a potential risk factor for abnormal brain aging

Journal of Alzheimer's Disease

Volumn 20, Issue 3, 2010, Pages 813-821

  Jefferson, Angela L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; cardiac output; cardiovascular disease; cognition

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; GLUCOSE; OXYGEN;

AGING; ALZHEIMER DISEASE; BODY SURFACE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN MATURATION; BRAIN PERFUSION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; GLUCOSE BRAIN LEVEL; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INDEX; HEART OUTPUT; HEART OUTPUT MEASUREMENT; HEART STROKE VOLUME; HEART TRANSPLANTATION; HEREDITY; HOMEOSTASIS; HUMAN; HYPERTENSION; MICROEMBOLISM; MICROVASCULATURE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROANATOMY; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SYSTEMIC CIRCULATION; SYSTOLIC BLOOD PRESSURE; THEORETICAL MODEL;

EID: 77954550095     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100081     Document Type: Review

References (76)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60, 1119-1122.
2. Carmelli D, Swan GE, Reed T,Wolf PA, Miller BL, DeCarli C (1999) Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 52, 1119-1124.
3. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Garner J, Jack L, Carmelli D (1999) Predictors of brain morphology for the men of the NHLBI twin study. Stroke 30, 529-536.
4. Muller M, Grobbee DE, Aleman A, Bots M, van der Schouw YT (2007) Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis 190, 143-149.
5. Borenstein AR, Wu Y, Mortimer JA, Schellenberg GD, Mc- Cormick WC, Bowen JD, McCurry S, Larson EB (2005) Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging 26, 325-334.
6. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62, 1556-1560. (Pubitemid 41434560)
7. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996) The progression from hypertension to congestive heart failure. JAMA 275, 1557-1562. (Pubitemid 26154241)
8. Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34, 29-34.
9. Tranmer BI, Keller TS, Kindt GW, Archer D (1992) Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia. J Neurosurg 77, 253-259.
10. Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, Thomsen G, Aldershvile J (2001) Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 32, 2530-2533. (Pubitemid 33055301)
11. Wanless RB, Anand IS, Gurden J, Harris P, Poole-Wilson PA (1987) Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 243, 1101-1106.
12. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283, 1007-1015.
13. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P (2004) Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 363, 2105-2115.
14. Williams M (2009) Progress in Alzheimer's disease drug discovery: an update. Curr Opin Investig Drugs 10, 23-34.
15. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351.
16. Khachaturian AS, Zandi PP,Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC (2006) Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol 63, 686-692.
17. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191.
18. Eisenberg S, Madison L, Sensenbach W (1960) Cerebral hemodynamic and metabolic studies in patients with congestive heart failure. II. Observations in confused subjects. Circulation 21, 704-709.
19. Sensenbach W, Madison L, Eisenberg S (1960) Cerebral hemodynamic and metabolic studies in patients with congestive heart failure. I. Observations in lucid subjects. Circulation 21, 697-703.
20. Editorial (1977) Cardiogenic Dementia. Lancet 1, 27-28.
21. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD (2000) The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cognit Psychol 41, 49-100.
22. Lane RJM (1991) 'Cardiogenic dementia' revisited. J R Soc Med 84, 577-579.
23. Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, Varricchio M, Rengo F (1998) Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc 46, 1343-1348.
24. Almeida OP, Tamai S (2001) Congestive heart failure and cognitive functioning amongst older adults. Arq Neuropsiquiatr 59, 324-329.
25. Incalzi R, Trojano L, Acanfora D, Crisci C, Tarantino F, Abete P, Rengo F (2003) Verbal memory impairment in congestive heart failure. J Clin Exp Neuropsychol 25, 14-23.
26. Lackey J (2004) Cognitive impairment and congestive heart failure. Nurs Stand 18, 33-36.
27. Trojano L, Antonelli Incalzi R, Acanfora D, PiconeC, Mecocci P, Rengo F (2003) Cognitive impairment: a key feature of congestive heart failure in the elderly. J Neurol 250, 1456-1463.
28. Bornstein RA, Starling RC, Myerowitz PD, Haas GJ (1995) Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation. Acta Neurol Scand 91, 260-265.
29. Polidori MC, Mariani E, Mecocci P, Nelles G (2006) Congestive heart failure and Alzheimer's disease. Neurol Res 28, 588-594.
30. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L (2006) Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med 166, 1003-1008.
31. Hoth KF, Poppas A, Moser DJ, Paul RH, Cohen RA (2008) Cardiac dysfunction and cognition in older adults with heart failure. Cogn Behav Neurol 21, 65-72.
32. Vogels RL, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, Schroeder-Tanka JM,Weinstein HC (2007) Profile of cognitive impairment in chronic heart failure. JAGS 55, 1764-1770.
33. Vogels RL, Oosterman JM, van Harten B, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC (2007) Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 24, 418-423.
34. Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R (1997) Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 63, 509-512.
35. Putzke JD, Williams MA, Rayburn BK, Kirklin JK, Boll TJ (1998) The relationship between cardiac function and neuropsychological status among heart transplant candidates. J Card Fail 4, 295-303.
36. Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM,Weinstein HC (2007) Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 9, 1003-1009.
37. Jefferson AL, Poppas A, Paul RH, Cohen RA (2007) Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 28, 477-483.
38. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
39. Jefferson AL, Tate DF, Poppas A, Brickman AM, Paul RH, Gunstad J, Cohen RA (2007) Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc 55, 1044-1048. (Pubitemid 47024621)
40. Jefferson AL, Beiser AS, Himali JJ, Au R, Massaro JM, Seshadri S, DeCarli C, O'Donnell CJ, Benjamin EJ, Wolf PA, Manning WJ (2008) Systolic function is associated with brain aging: The Framingham Heart Study. Alzheimers Dement 4(Suppl), T676.
41. Jefferson AL, Himali J, Beiser A, Au R, Massaro J, Seshadri S, DeCarli C, O'Donnell C, Benjamin E,Wolf P, Manning W (2010) Cardiac function is associated with brain aging: The Framingham Heart Study. Circulation, under review.
42. Jefferson AL, Holland CM, Tate DF, Poppas A, Csapo I, Cohen RA, Guttman CRG (2009) Atlas-derived perfusion correlates of white matter hyperintensities in patients with reduced cardiac output. Neurobiol Aging, in press.
43. Saxena PR, Schoemaker RG (1993) Organ blood flow protection in hypertension and congestive heart failure. Am J Med 94, 4S-12S.
44. Shapiro W, Chawla NP (1969) Observations on the regulation of cerebral blood flow in complete heart block. Circulation 40, 863-870.
45. Massaro AR, Dutra AP, Almeida DR, Diniz RV, Malheiros SM (2006) Transcranial Doppler assessment of cerebral blood flow: effect of cardiac transplantation. Neurology 66, 124-126.
46. Deshields TL, McDonough EM, Mannen RK, Miller LW (1996) Psychological and cognitive status before and after heart transplantation. Gen Hosp Psychiatry 18, 62S-69S.
47. Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ (1997) Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol 19, 692-697.
48. Felder RB, Francis J, Zhang ZH,Wei SG,Weiss RM, Johnson AK (2003) Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 284, R259-R276.
49. Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromotogr B Analyt Technol Biomed Life Sci 827, 65-75.
50. Jefferson AL, Massaro JM, Larson MG, Wolf PA, Au R, D'Agostino RB, Seshadri S, Lipinska I, Meigs JB, Keaney Jr. JF, Vasan RS, Beiser A, Benjamin EJ, DeCarli C (2007) Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study. Neurology 68, 1032-1038.
51. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27, 1201-1206.
52. del Zoppo GJ, Mabuchi T (2003) Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23, 879-894.
53. Hayashi T, Deguchi K, Nagotani S, Zhang H, Sehara Y, Tsuchiya A, Abe K (2006) Cerebral ischemia and angiogenesis. Curr Neurovasc Res 3, 119-129.
54. Yoshizaki K, Adachi K, Kataoka S, Watanabe A, Tabira T, Takahashi K,WakitaH(2008) Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice. Exp Neurol 210, 585-591.
55. Shibata M, Ohtani R, Ihara M, Tomimoto H (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35, 2598-2603.
56. Hatazawa J, Shimosegawa E, Satoh T, Toyoshima H, Okudera T (1997) Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. Stroke 28, 1944-1947.
57. Marstrand JR, Garde E, Rostrup E, Ring P, Rosenbaum S, Mortensen EL, Larsson HB (2002) Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 33, 972-976.
58. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43, 1683-1689.
59. Pullicino P, Mifsud V, Wong E, Graham S, Ali I, Smajlovic D (2001) Hypoperfusion-related cerebral ischemia and cardiac left ventricular systolic dysfunction. J Stroke Cerebrovasc Dis 10, 178-182.
60. Vosko MR, Rother J, Friedl B, Bultemeier G, Kloss CU, Hamann GF (2003) Microvascular damage following experimental sinus-vein thrombosis in rats. Acta Neuropathol (Berl) 106, 501-505.
61. Nakase H, Kempski OS, Heimann A, Takeshima T, Tintera J (1997) Microcirculation after cerebral venous occlusions as assessed by laser Doppler scanning. J Neurosurg 87, 307-314.
62. Purandare N, Voshaar RC, Morris J, Byrne JE, Wren J, Heller RF, McCollum CN, Burns A (2007) Asymptomatic spontaneous cerebral emboli predict cognitive and functional decline in dementia. Biol Psychiatry 62, 339-344. (Pubitemid 47444282)
63. Aliev G, Smith MA, de la Torre JC, Perry G (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 4, 649-663.
64. Alsop DC, Detre JA, GrossmanM(2000) Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 47, 93-100.
65. Maalikjy Akkawi N, Borroni B, Agosti C, Pezzini A, Magoni M, Rozzini L, Prometti P, Romanelli G, Vignolo LA, Padovani A (2003) Volume reduction in cerebral blood flow in patients with Alzheimer's disease: a sonographic study. Dement Geriatr Cogn Disord 16, 163-169.
66. Maalikjy Akkawi N, Borroni B, Agosti C, Magoni M, Broli M, Pezzini A, Padovani A (2005) Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study. J Neurol 252, 559-563.
67. Meltzer CC, Zubieta JK, Brandt J, Tune LE, Mayberg HS, Frost JJ (1996) Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 47, 454-461.
68. Skoog I, Kalaria RN, Breteler MM (1999) Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13(Suppl 3), S106-114.
69. Pluta R (2000) The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease. Ann N Y Acad Sci 903, 324-334.
70. Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Frishman WH, Fisher D, Katzman R (1990) Women, myocardial infarction, and dementia in the very old. Neurology 40, 1102-1106.
71. Buee L, Hof PR, Delacourte A (1997) Brain microvascular changes in Alzheimer's disease and other dementias. Ann NY Acad Sci 826, 7-24.
72. Kalaria RN (1997) Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann NY Acad Sci 826, 263-271.
73. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817.
74. Rossi R, Geroldi C, Bresciani L, Testa C, Binetti G, Zanetti O, Frisoni GB (2007) Clinical and neuropsychological features associated with structural imaging patterns in patients with mild cognitive impairment. Dement Geriatr Cogn Disord 23, 175-183.
75. Debette S, Bombois S, Bruandet A, Delbeuck X, Lepoittevin S, Delmaire C, Leys D, Pasquier F (2007) Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 38, 2924-2930.
76. Sweitzer NK, Lopatin M, Yancy CW, Mills RM, Stevenson LW (2008) Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or = 55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (< 40%) fractions. Am J Cardiol 101, 1151-1156.